United Therapeutics UTHR Other — Cost of Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's other — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is United Therapeutics's other — cost of sales?
- United Therapeutics (UTHR) reported other — cost of sales of $12.1M in Q1 2026.
- How has United Therapeutics's other — cost of sales changed year-over-year?
- United Therapeutics's other — cost of sales increased by 101.7% year-over-year, from $6M to $12.1M.
- What does other — cost of sales mean?
- This metric measures the direct costs associated with producing or delivering the goods and services within the company's non-core business segments. It includes expenses such as raw materials, direct labor, and manufacturing overhead specifically allocated to these secondary operations. Monitoring this cost structure is essential for evaluating the operational efficiency and scalability of the company's peripheral business units.